Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

665 related articles for article (PubMed ID: 25560309)

  • 1. Targeting delivery of etoposide to inhibit the growth of human glioblastoma multiforme using lactoferrin- and folic acid-grafted poly(lactide-co-glycolide) nanoparticles.
    Kuo YC; Chen YC
    Int J Pharm; 2015 Feb; 479(1):138-49. PubMed ID: 25560309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition against growth of glioblastoma multiforme in vitro using etoposide-loaded solid lipid nanoparticles with p-aminophenyl-α-D-manno-pyranoside and folic acid.
    Kuo YC; Lee CH
    J Pharm Sci; 2015 May; 104(5):1804-14. PubMed ID: 25694089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting nevirapine delivery across human brain microvascular endothelial cells using transferrin-grafted poly(lactide-co-glycolide) nanoparticles.
    Kuo YC; Lin PI; Wang CC
    Nanomedicine (Lond); 2011 Aug; 6(6):1011-26. PubMed ID: 21707298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Etoposide encapsulation in surface-modified poly(lactide-co-glycolide) nanoparticles strongly enhances glioma antitumor efficiency.
    Callewaert M; Dukic S; Van Gulick L; Vittier M; Gafa V; Andry MC; Molinari M; Roullin VG
    J Biomed Mater Res A; 2013 May; 101(5):1319-27. PubMed ID: 23065812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and characterization of teniposide PLGA nanoparticles and their uptake in human glioblastoma U87MG cells.
    Mo L; Hou L; Guo D; Xiao X; Mao P; Yang X
    Int J Pharm; 2012 Oct; 436(1-2):815-24. PubMed ID: 22846410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted delivery of etoposide, carmustine and doxorubicin to human glioblastoma cells using methoxy poly(ethylene glycol)‑poly(ε‑caprolactone) nanoparticles conjugated with wheat germ agglutinin and folic acid.
    Kuo YC; Chang YH; Rajesh R
    Mater Sci Eng C Mater Biol Appl; 2019 Mar; 96():114-128. PubMed ID: 30606517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transport of saquinavir across human brain-microvascular endothelial cells by poly(lactide-co-glycolide) nanoparticles with surface poly-(γ-glutamic acid).
    Kuo YC; Yu HW
    Int J Pharm; 2011 Sep; 416(1):365-75. PubMed ID: 21736932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual targeting of solid lipid nanoparticles grafted with 83-14 MAb and anti-EGF receptor for malignant brain tumor therapy.
    Kuo YC; Lee CH
    Life Sci; 2016 Feb; 146():222-31. PubMed ID: 26784850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and characterization of folate anchored Saquinavir entrapped PLGA nanoparticles for anti-tumor activity.
    Singh R; Kesharwani P; Mehra NK; Singh S; Banerjee S; Jain NK
    Drug Dev Ind Pharm; 2015; 41(11):1888-901. PubMed ID: 25738812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain targeted delivery of carmustine using solid lipid nanoparticles modified with tamoxifen and lactoferrin for antitumor proliferation.
    Kuo YC; Cheng SJ
    Int J Pharm; 2016 Feb; 499(1-2):10-19. PubMed ID: 26721730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-aggregated protamine-coated poly(lactide-co-glycolide) nanoparticles of cisplatin crossed blood-brain barrier, enhanced drug delivery and improved therapeutic index in glioblastoma cells: in vitro studies.
    Dhami NK; Pandey RS; Jain UK; Chandra R; Madan J
    J Microencapsul; 2014; 31(7):685-93. PubMed ID: 24963955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folate-receptor-targeted laser-activable poly(lactide-
    Liu F; Chen Y; Li Y; Guo Y; Cao Y; Li P; Wang Z; Gong Y; Ran H
    Int J Nanomedicine; 2018; 13():5139-5158. PubMed ID: 30233177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein functionalized tramadol-loaded PLGA nanoparticles: preparation, optimization, stability and pharmacodynamic studies.
    Lalani J; Rathi M; Lalan M; Misra A
    Drug Dev Ind Pharm; 2013 Jun; 39(6):854-64. PubMed ID: 22799442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translocator protein ligand-PLGA conjugated nanoparticles for 5-fluorouracil delivery to glioma cancer cells.
    Laquintana V; Denora N; Lopalco A; Lopedota A; Cutrignelli A; Lasorsa FM; Agostino G; Franco M
    Mol Pharm; 2014 Mar; 11(3):859-71. PubMed ID: 24410438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folate-modified PLGA nanoparticles for tumor-targeted delivery of pheophorbide a in vivo.
    Son J; Yang SM; Yi G; Roh YJ; Park H; Park JM; Choi MG; Koo H
    Biochem Biophys Res Commun; 2018 Apr; 498(3):523-528. PubMed ID: 29518390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer's disease.
    Meng Q; Wang A; Hua H; Jiang Y; Wang Y; Mu H; Wu Z; Sun K
    Int J Nanomedicine; 2018; 13():705-718. PubMed ID: 29440896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced delivery of etoposide across the blood-brain barrier to restrain brain tumor growth using melanotransferrin antibody- and tamoxifen-conjugated solid lipid nanoparticles.
    Kuo YC; Wang IH
    J Drug Target; 2016 Aug; 24(7):645-54. PubMed ID: 26768307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced cellular uptake of folic acid-conjugated PLGA-PEG nanoparticles loaded with vincristine sulfate in human breast cancer.
    Chen J; Li S; Shen Q; He H; Zhang Y
    Drug Dev Ind Pharm; 2011 Nov; 37(11):1339-46. PubMed ID: 21524153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lactoferrin-modified poly(ethylene glycol)-grafted BSA nanoparticles as a dual-targeting carrier for treating brain gliomas.
    Su Z; Xing L; Chen Y; Xu Y; Yang F; Zhang C; Ping Q; Xiao Y
    Mol Pharm; 2014 Jun; 11(6):1823-34. PubMed ID: 24779677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carboxymethyl-β-cyclodextrin conjugated nanoparticles facilitate therapy for folate receptor-positive tumor with the mediation of folic acid.
    Su C; Li H; Shi Y; Wang G; Liu L; Zhao L; Su R
    Int J Pharm; 2014 Oct; 474(1-2):202-11. PubMed ID: 25149123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.